ArticleJournal of molecular neuroscience : MN2026

MYH2 as a Potential Modifier of Clinical Severity in Facioscapulohumeral Muscular Dystrophy.

Ceren Hangül et al.PubMed ↗Publisher ↗

No numbers read from the abstract.